New SEC Form D filing
Hexamer Therapeutics, Inc, 2026-09-15
A new SEC Form D private-offering notice from Pullman, WA, a $2,500,000 filer-stated offering target in Biotech. The source filing is one click away.
What this filing says
Develops a self assembling peptide based vaccine platform for infectious diseases and cancer.
Filed 3 days agoFiled to raise $2,500,000First money in 2026-07-07Raised so far $500,000HQ (as filed) Pullman, WASector Biotech web-verified against the company’s own siteStage (inferred) SeedCall status Delayed filing
Source linked the Form D on EDGAR↗Website verified hexamertherapeutics.com↗Named in the filing 6 executives & directors
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR sourceThe Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.